Aditxt, Inc. (NASDAQ:ADTX) Short Interest Update

Aditxt, Inc. (NASDAQ:ADTX) was the target of a large growth in short interest in October. As of October 15th, there was short interest totalling 450,400 shares, a growth of 7,665.5% from the September 30th total of 5,800 shares. Approximately 10.7% of the company’s stock are short sold. Based on an average trading volume of 1,810,000 shares, the short-interest ratio is currently 0.2 days.

Aditxt Price Performance

NASDAQ ADTX opened at $0.80 on Friday. Aditxt has a 52-week low of $0.79 and a 52-week high of $380.00. The firm has a 50-day moving average price of $14.79 and a 200 day moving average price of $53.37.

Aditxt (NASDAQ:ADTX) last issued its earnings results on Monday, August 19th. The company reported ($167.60) earnings per share (EPS) for the quarter. The firm had revenue of $0.04 million during the quarter.

Insider Transactions at Aditxt

In other news, major shareholder Financial Lp Hrt sold 25,534 shares of the business’s stock in a transaction dated Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total value of $29,874.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.23% of the company’s stock.

About Aditxt

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.